Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-21-000045 General Corporate
Debt relative to revenue 45th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.debt_to_revenue
629.12% · OPTIONAL · VALID
Capex intensity 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.71% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
46.78% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
13.61% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 27th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
14.30% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
59.38% · CORE · VALID
Operating margin 100th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
27.60% · CORE · VALID
R&D intensity 9th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
18.20% · OPTIONAL · VALID
SBC intensity 27th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
6.67% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Feb 3, 2019 0/8 normalized Level 3 May 5, 2019 0/9 normalized Level 3 Aug 4, 2019 0/9 normalized Level 3 Nov 3, 2019 0/9 normalized Level 3 Feb 2, 2020 0/9 normalized Level 3 May 3, 2020 6/9 normalized Level 3 Aug 2, 2020 8/9 normalized Level 3 Nov 1, 2020 8/9 normalized Level 3 Jan 31, 2021 8/9 normalized Level 3 May 2, 2021 9/9 normalized Level 3 Aug 1, 2021 9/9 normalized Level 3 Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 8/8 normalized Level 3 Jan 29, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 171.89%
Current 629.12%
Delta 457.23% Capex Intensity Decreased
Previous 1.94%
Current 1.71%
Delta -0.23% Cash Generation Decreased
Previous 50.49%
Current 46.78%
Delta -3.71% Growth Increased
Previous 5.71%
Current 13.61%
Delta 7.89% Inventory Pressure Increased
Previous 4.20%
Current 14.30%
Delta 10.11% Margin Increased
Previous 56.58%
Current 59.38%
Delta 2.80% Profitability Increased
Previous 16.80%
Current 27.60%
Delta 10.80% R And D Intensity Decreased
Previous 20.80%
Current 18.20%
Delta -2.60% Sbc Intensity Decreased
Previous 8.27%
Current 6.67%
Delta -1.60% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.